Ro, a New York-based direct-to-patient healthcare company, raised $150M in funding.
The round was led by ShawSpring Partners, with participation from General Catalyst, FirstMark Capital, TQ Ventures, SignalFire, BoxGroup, The Chernin Group, Initialized Capital, Altimeter Capital, Baupost Group, and Seven Seven Six.
The company intends to use the funds to to strengthen its position in direct-to-patient care — a model of healthcare that uses technology to reduce costs, expand access, and empower patients.
Led by CEO Zachariah Reitano, Ro is a direct-to-patient healthcare company providing healthcare without the need for insurance. It connects telehealth and in-home care, diagnostics, labs, and pharmacy services nationwide. This is enabled by a vertically integrated platform that powers a personalized, end-to-end healthcare experience from diagnosis, to delivery of medication, to ongoing care. Since 2017, Ro has facilitated more than eight million digital healthcare visits in nearly every county in the United States, including 98% of primary care deserts. Ro also provides its patient-centric solutions including Workpath, its in-home care API, and Kit, its at-home diagnostic testing service, to other healthcare companies.
FinSMEs
15/02/2022